These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9707765)

  • 21. [Treatment of benign prostatic hyperplasia (BPH) by transurethral needle ablation (TUNA) and 36-month follow-up of the retreatment rate].
    Martin X; Claude A; Colombel M; Sarramon JP; Ballanger P; Lobel B; Richard F; Saussine C; Cavillon C; Buzelin JM; Baron JC; Lambert D; Haillot O
    Prog Urol; 2005 Sep; 15(4):674-80. PubMed ID: 16459684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of transurethral enucleation with bipolar and transurethral resection in saline for managing benign prostatic hyperplasia.
    Hirasawa Y; Ide H; Yasumizu Y; Hoshino K; Ito Y; Masuda T
    BJU Int; 2012 Dec; 110(11 Pt C):E864-9. PubMed ID: 22938513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transurethral Needle Ablation of the prostate (TUNA): clinical results and ultrasound, endoscopic, and histologic findings in pilot study of patients in urinary retention.
    Harewood LM; Cleeve LK; O'Connell HE; Pope AJ; Vaughan MG; Agarwal D
    J Endourol; 1995 Oct; 9(5):407-12. PubMed ID: 8580942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transurethral plasma vaporization of the prostate: 3-month functional outcome and complications.
    Robert G; Descazeaud A; Delongchamps NB; Ballereau C; Haillot O; Saussine C; Kleinklauss F; Pasticier G; Azzouzi AR; Lukacs B; Dumonceau O; Fourmarier M; De La Taille A; Devonec M
    BJU Int; 2012 Aug; 110(4):555-60. PubMed ID: 21044248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of benign prostatic hyperplasia by radiofrequency (TUNA): a monocentric study of 28 cases treated in ambulatory surgery].
    Le Gal S; Fouques Y; Mallick S; Taksin L; Le Toquin-Bernard S; Frachet O; Bensadoun H
    Prog Urol; 2009 May; 19(5):327-32. PubMed ID: 19393538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate.
    Volkan T; Ihsan TA; Yilmaz O; Emin O; Selcuk S; Koray K; Bedi O
    Eur Urol; 2005 Oct; 48(4):608-13. PubMed ID: 16135396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation.
    Pereira-Correia JA; de Moraes Sousa KD; Santos JB; de Morais Perpétuo D; Lopes-da-Silva LF; Krambeck RL; Muller VJ; Vaz FP
    BJU Int; 2012 Oct; 110(8):1184-9. PubMed ID: 22257240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
    Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
    BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study.
    Bachmann A; Tubaro A; Barber N; d'Ancona F; Muir G; Witzsch U; Grimm MO; Benejam J; Stolzenburg JU; Riddick A; Pahernik S; Roelink H; Ameye F; Saussine C; Bruyère F; Loidl W; Larner T; Gogoi NK; Hindley R; Muschter R; Thorpe A; Shrotri N; Graham S; Hamann M; Miller K; Schostak M; Capitán C; Knispel H; Thomas JA
    Eur Urol; 2014 May; 65(5):931-42. PubMed ID: 24331152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
    de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
    Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiofrequency thermal ablation of the prostate: the TUNA technique.
    Heaton JP
    Tech Urol; 1995; 1(1):3-10. PubMed ID: 9118364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia.
    Kaplan SA; Te AE
    Urology; 1995 Apr; 45(4):566-72. PubMed ID: 7536365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy.
    Laguna MP; Kiemeney LA; Debruyne FM; de la Rosette JJ
    J Urol; 2002 Apr; 167(4):1727-30. PubMed ID: 11912397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma kinetic vaporization of the prostate: clinical evaluation of a new technique.
    Dincel C; Samli MM; Guler C; Demirbas M; Karalar M
    J Endourol; 2004 Apr; 18(3):293-8. PubMed ID: 15225397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia.
    Tubaro A; Carter S; Hind A; Vicentini C; Miano L
    J Urol; 2001 Jul; 166(1):172-6. PubMed ID: 11435849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long-term results of transurethral vaporization of the prostate using plasmakinetic energy.
    Kaya C; Ilktac A; Gokmen E; Ozturk M; Karaman IM
    BJU Int; 2007 Apr; 99(4):845-8. PubMed ID: 17378844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
    Gerber GS; Jahoda A; Bales GT; Albala DM
    Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative randomized study on the efficaciousness of endoscopic bipolar prostate resection versus monopolar resection technique. 3 year follow-up.
    Giulianelli R; Albanesi L; Attisani F; Gentile BC; Vincenti G; Pisanti F; Shestani T; Mavilla L; Granata D; Schettini M
    Arch Ital Urol Androl; 2013 Jun; 85(2):86-91. PubMed ID: 23820656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.